Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix and Cyrano Sciences to Co-Develop Chemical Sensors

NEW YORK, Jan. 12 (GenomeWeb News) - Acacia Research said today that its CombiMatrix microarray subsidiary will collaborate with Cyrano Sciences to develop chemical sensors that use both companies' technologies.

 

CombiMatrix, based in Mulkiteo, Wash., will contribute its microarray technology and Cyrano, located in Pasadena, Calif., its nanocomposite sensor or "electronic nose" technology to develop biochips for sensing chemical agents in air and water.

 

Up until now, CombiMatrix has developed its array technology for applications in genetic analysis, RNAi drug discovery, biodefense applications, and nanomaterials discovery.

 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more